Trends in Opioid Use Disorder Diagnoses, Hospitalizations,
and Receipt of Treatment in the U.S., 2021-2024

Sponsored by

INOV-Trends-in-Opiod-Use-Disorder-Diagnoses-8

Opioid use disorder (OUD) continues to carry significant clinical and economic impact across the U.S. healthcare system. Leveraging a large, nationally representative database, this white paper examines differences in OUD-related hospitalizations and treatment patterns across payer types, demographics, and states—illuminating disparities that can inform evidence-based strategies.

In this content, you will learn:

How real-world data reveal payer-specific differences in hospitalizations and post-discharge treatment for OUD.
Insights into high-risk periods, including the elevated risk of overdose following an OUD-related hospitalization.
Key trends from 2021–2024 in opioid prescribing, including decreases among commercially insured patients and increases among Medicaid patients.
How timely, data-driven insights can guide targeted interventions to improve outcomes and reduce system costs.

Email*(Required)

First Name*(Required)

Last Name*(Required)

Company Name*(Required)

Job title*(Required)

Phone Number*(Required)

State/Region*(Required)

Zip Code*(Required)

Line of Business

1. What is your role in the decision-making process for Real-World Data (RWD) or Health Economics and Outcomes Research (HEOR) solutions?*

Evaluator

Influencer

Decision-Maker

Economic Decision-Maker

2. What are the primary goals of your RWD or HEOR strategy? (Select all that apply)*

Regulatory Support: Submitting evidence for approvals, post-market surveillance, or expanded indications.

Payer and Market Access: Strengthening value dossiers, demonstrating cost-effectiveness, or securing reimbursement.

Product Differentiation: Highlighting unique real-world outcomes or creating compelling marketing claims.

Patient Insights: Understanding patient journeys, enhancing patient-reported outcomes, or improving recruitment.

Operational Efficiency: Streamlining data integration, analytics, or reducing project timelines and costs.

Scientific Research: Generating publications, advancing therapeutic knowledge, or supporting conference presentations.

Data-Driven Decision-Making: Providing real-time insights or leveraging predictive analytics for innovation

Optimizing Clinical Trials: Leveraging real-world data to enhance patient recruitment, streamline site selection, and reduce reliance on placebo arms for faster, cost-effective trials.

3. Are you currently evaluating Real-World Data (RWD) or Health Economics and Outcomes Research (HEOR) solutions? If yes, what is your expected timeline for making a decision?*

YES

If "Yes," please specify your timeline:*

By submitting this form, you agree to have your contact information, including email and phone, processed by TopicPro and the sponsors of this page for the purpose of following up on your professional interests.*

TopicPro needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Terms of Use & Privacy Policy.

Trends in Opioid Use Disorder Diagnoses, Hospitalizations, and Receipt of Treatment in the U.S., 2021-2024

Trends in Opioid Use Disorder Diagnoses, Hospitalizations,
and Receipt of Treatment in the U.S., 2021-2024